HOOKIPA Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Revenue	20.13	14.25	18.45	19.58	11.94	Upgrade
Revenue Growth (YoY)	41.27%	-22.76%	-5.80%	63.99%	56.53%	Upgrade
Gross Profit	20.13	14.25	18.45	19.58	11.94	Upgrade
Selling, General & Admin	18.63	18.76	17.27	18.08	16.72	Upgrade
Research & Development	86.42	68.65	82.85	54.79	46.31	Upgrade
Other Operating Expenses	12.77	0	0	0	0	Upgrade
Operating Expenses	117.82	87.4	100.12	72.87	63.03	Upgrade
Operating Income	-97.69	-73.16	-81.67	-53.29	-51.09	Upgrade
Interest Expense / Income	0.32	0.69	0.9	0.79	0.88	Upgrade
Other Expense / Income	-16.8	-9.16	-6.91	-9.99	-8.93	Upgrade
Pretax Income	-81.21	-64.69	-75.66	-44.08	-43.04	Upgrade
Income Tax	0.37	0.23	0	0	0	Upgrade
Net Income	-81.58	-64.92	-75.67	-44.08	-43.04	Upgrade
Shares Outstanding (Basic)	84	55	30	26	18	Upgrade
Shares Outstanding (Diluted)	-	-	-	-	18	Upgrade
Shares Change	53.43%	82.64%	16.71%	43.73%	1853.24%	Upgrade
EPS (Basic)	-0.86	-0.99	-2.30	-1.69	-2.41	Upgrade
EPS (Diluted)	-0.86	-0.99	-2.30	-1.69	-2.41	Upgrade
Free Cash Flow	-61.68	-25.01	-78.6	-41.71	-43.73	Upgrade
Free Cash Flow Per Share	-0.73	-0.46	-2.62	-1.63	-2.45	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-485.34%	-513.40%	-442.73%	-272.08%	-427.78%	Upgrade
Profit Margin	-405.29%	-455.58%	-410.15%	-225.09%	-360.38%	Upgrade
Free Cash Flow Margin	-306.44%	-175.55%	-426.05%	-212.98%	-366.19%	Upgrade
EBITDA	-77.34	-60.4	-70.13	-39.15	-39.09	Upgrade
EBITDA Margin	-384.24%	-423.86%	-380.13%	-199.89%	-327.36%	Upgrade
Depreciation & Amortization	3.55	3.6	4.64	4.15	3.07	Upgrade
EBIT	-80.9	-64	-74.77	-43.3	-42.16	Upgrade
EBIT Margin	-401.88%	-449.14%	-405.28%	-221.08%	-353.04%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).